Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.5M Buy
162,408
+25,139
+18% +$2.9M 0.79% 25
2025
Q4
$14.4M Buy
137,269
+9,354
+7% +$878K 0.59% 30
2025
Q3
$10.7M Buy
127,915
+13,151
+11% +$1.08M 0.46% 39
2025
Q2
$9.08M Buy
114,764
+8,414
+8% +$669K 0.44% 38
2025
Q1
$9.55M Buy
106,350
+5,455
+5% +$509K 0.53% 35
2024
Q4
$10M Buy
100,895
+5,555
+6% +$573K 0.56% 29
2024
Q3
$10.8M Buy
95,340
+3,235
+4% +$384K 0.62% 27
2024
Q2
$11.4M Buy
92,105
+2,248
+3% +$290K 0.71% 25
2024
Q1
$11.9M Buy
89,857
+804
+0.9% +$99.1K 0.79% 22
2023
Q4
$9.71M Buy
89,053
+12,716
+17% +$1.32M 0.72% 28
2023
Q3
$7.86M Buy
76,337
+10,484
+16% +$1.13M 0.66% 27
2023
Q2
$7.6M Buy
65,853
+1,568
+2% +$178K 0.64% 22
2023
Q1
$6.84M Buy
64,285
+386
+0.6% +$41.7K 0.62% 24
2022
Q4
$7.09M Buy
63,899
+1,704
+3% +$174K 0.69% 24
2022
Q3
$5.36M Buy
62,195
+46,445
+295% +$4.15M 0.59% 26
2022
Q2
$1.44M Buy
15,750
+1,095
+7% +$97.1K 0.15% 76
2022
Q1
$1.2M Buy
14,655
+1,199
+9% +$94.5K 0.12% 85
2021
Q4
$1.03M Buy
13,456
+9,781
+266% +$779K 0.1% 103
2021
Q3
$276K Buy
+3,675
New +$279K 0.04% 250

Other funds holding MRK

JB Capital's MRK Position: Q1 2026 in Review

JB Capital increased its Merck (MRK) stake by 18% in Q1 2026, buying an estimated $2.9M and bringing the position to 162,408 shares worth $19.5M. The position accounts for 0.79% of the portfolio, ranked #25.

JB Capital first reported a position in MRK in Q3 2021 and has held it in 19 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • JB Capital held 162,408 shares of Merck worth $19.5M as of Q1 2026.
  • JB Capital bought 25,139 Merck shares in Q1 2026, an estimated $2.9M.
  • Merck made up 0.79% of JB Capital's portfolio in Q1 2026, its #25 holding.
  • JB Capital first reported a position in Merck in Q3 2021 and has held it in 19 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on JB Capital's 13F filing for Q1 2026, filed 27 Apr 2026.